Concepedia

Asser S. Andersen

AS

Statistics

Publications

38

Citations

2.5K

H-Index

27

Active since

1989

Affiliations

Novo Nordisk (Denmark)(Current)

Dorn Research Institute

Statens Serum Institut

Bispebjerg Hospital

Novozymes (Denmark)

Asser S. Andersen is an author at Novo Nordisk (Denmark) specializing in life sciences, biochemistry, and insulin receptors.

ORCID

Publications per year

1989–2021

38

Publications

38

Soluble, fatty acid acylated insulins bind to albumin and show protracted action in pigs

Jan Markussen, Svend Havelund, Peter Kurtzhals et al. · Diabetologia · 1996 · 226 citations

, , +13

Alanine Scanning Mutagenesis of Insulin

Claus Kristensen, Thomas Kjeldsen, Finn C. Wiberg et al. · Journal of Biological Chemistry · 1997 · 211 citations · Full text

, , +15

Hybrid Receptors Formed by Insulin Receptor (IR) and Insulin-like Growth Factor I Receptor (IGF-IR) Have Low Insulin and High IGF-1 Affinity Irrespective of the IR Splice Variant

Rita Slaaby, Lauge Schäffer, Inger Lautrup-Larsen et al. · Journal of Biological Chemistry · 2006 · 193 citations · Full text

, , +13

The ligand specificities of the insulin receptor and the insulin-like growth factor I receptor reside in different regions of a common binding site.

Thomas Kjeldsen, Asser S. Andersen, Finn C. Wiberg et al. · Proceedings of the National Academy of Sciences · 1991 · 140 citations

, , +17

A novel approach to the antimicrobial activity of maggot debridement therapy

Asser S. Andersen, Dorthe Sandvang, Kirk Schnorr et al. · Journal of Antimicrobial Chemotherapy · 2010 · 138 citations · Full text

, , +14

1–5 of 38